Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Transplantation

  Free Subscription


Articles published in Transplantation

Retrieve available abstracts of 192 articles:
HTML format
Text format



Single Articles


    May 2017

  1. Early Introduction of Subcutaneous Hepatitis B Immunoglobulin Following Liver Transplantation for Hepatitis B Virus Infection: A Prospective, Multicenter Study: Erratum.
    Transplantation. 2017;101:e193.
    PubMed     Text format    


  2. TERRAULT NA, Berenguer M, Strasser SI, Gadano A, et al
    International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Recipients.
    Transplantation. 2017;101:956-967.
    PubMed     Text format    


  3. TERRAULT NA, McCaughan GW, Curry MP, Gane E, et al
    International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates.
    Transplantation. 2017;101:945-955.
    PubMed     Text format    


  4. MILLER CM, Quintini C, Dhawan A, Durand F, et al
    The International Liver Transplantation Society Living Donor Liver Transplant Recipient Guideline.
    Transplantation. 2017;101:938-944.
    PubMed     Text format     Abstract available


    April 2017
  5. O'LEARY JG, Smith C, Cai J, Hart B, et al
    Chronic AMR in Liver Transplant: Validation of the 1-Year cAMR score's Ability to Determine Long-Term Outcome.
    Transplantation. 2017 Apr 27. doi: 10.1097/TP.0000000000001802.
    PubMed     Text format     Abstract available


  6. DE BOER JD, Blok JJ, Braat AE
    Graft Quality and Prediction of Outcome After Liver Transplantation.
    Transplantation. 2017 Apr 18. doi: 10.1097/TP.0000000000001781.
    PubMed     Text format    


  7. COMPAGNON P, Levesque E, Hentati H, Disabato M, et al
    An Oxygenated and Transportable Machine Perfusion System Fully Rescues Liver Grafts Exposed to Lethal Ischemic Damage in a Pig Model of DCD Liver Transplantation.
    Transplantation. 2017 Apr 11. doi: 10.1097/TP.0000000000001764.
    PubMed     Text format     Abstract available


  8. MAZZOLA A, Minh MT, Charlotte F, Hdjii A, et al
    Chronic hepatitis E viral infection after liver transplantation: a regression of fibrosis following antiviral therapy.
    Transplantation. 2017 Apr 4. doi: 10.1097/TP.0000000000001766.
    PubMed     Text format     Abstract available


  9. NEUBERGER JM, Bechstein WO, Kuypers DR, Burra P, et al
    Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group.
    Transplantation. 2017;101.
    PubMed     Text format     Abstract available


  10. OLIVER JB, Marcus AF, Paster M, Nespral J, et al
    Organ Procurement Organization Survey of Practices and Beliefs Regarding Prerecovery Percutaneous Liver Biopsy in Donation After Neurologic Determination of Death.
    Transplantation. 2017;101:821-825.
    PubMed     Text format     Abstract available


  11. COLLETT D, Friend PJ, Watson CJ
    Factors Associated With Short- and Long-term Liver Graft Survival in the United Kingdom: Development of a UK Donor Liver Index.
    Transplantation. 2017;101:786-792.
    PubMed     Text format     Abstract available


    March 2017
  12. MEHTA N, Heimbach J, Lee D, Dodge JL, et al
    Wait Time of < 6 and > 18 Months Predicts Hepatocellular Carcinoma Recurrence after Liver Transplantation: Proposing a Wait Time "Sweet Spot".
    Transplantation. 2017 Mar 28. doi: 10.1097/TP.0000000000001752.
    PubMed     Text format     Abstract available


  13. SHENG M, Lin Y, Weng Y, Xu R, et al
    Predictive Value of Intraoperative Troponin I Elevation in Pediatric Living Donor Liver Transplant Recipients With Biliary Atresia.
    Transplantation. 2017 Mar 18. doi: 10.1097/TP.0000000000001732.
    PubMed     Text format     Abstract available


  14. PARLAK E, Koksal AS, Eminler AT, Toka B, et al
    Treatment of Biliary Stricture After Live Donor Liver Transplantation With Combined Metal and Plastic Stent Insertion: A Feasibility and Safety Study.
    Transplantation. 2017 Mar 18. doi: 10.1097/TP.0000000000001734.
    PubMed     Text format     Abstract available


  15. NEKRASOV V, Matsuoka L, Kaur N, Pita A, et al
    Improvement in the Outcomes of MELD >/= 40 Liver Transplantation: An Analysis of 207 Consecutive Transplants in a Highly Competitive DSA.
    Transplantation. 2017 Mar 18. doi: 10.1097/TP.0000000000001738.
    PubMed     Text format     Abstract available


  16. KONERMAN MA, Fritze D, Weinberg RL, Sonnenday CJ, et al
    Incidence of and Risk Assessment for Adverse Cardiovascular Outcomes Following Liver Transplantation: A Systematic Review.
    Transplantation. 2017 Mar 15. doi: 10.1097/TP.0000000000001710.
    PubMed     Text format     Abstract available


  17. BHATI C, Idowu MO, Sanyal AJ, Rivera M, et al
    Long Term Outcomes in Patients Undergoing Liver Transplantation for Nonalcoholic Steatohepatitis Related Cirrhosis.
    Transplantation. 2017 Mar 15. doi: 10.1097/TP.0000000000001709.
    PubMed     Text format     Abstract available


  18. MURALI AR, Patil S, Phillips KT, Voigt M, et al
    Locoregional Therapy with Curative Intent versus Primary Liver Transplant for Hepatocellular Carcinoma: Systematic Review and Meta-analysis.
    Transplantation. 2017 Mar 10. doi: 10.1097/TP.0000000000001730.
    PubMed     Text format     Abstract available


  19. MOUCHLI MA, Singh S, Loftus EV Jr, Boardman L, et al
    Risk Factors and Outcomes of De novo Cancers (Excluding Nonmelanoma Skin Cancer) after Liver Transplantation for Primary Sclerosing Cholangitis.
    Transplantation. 2017 Mar 8. doi: 10.1097/TP.0000000000001725.
    PubMed     Text format     Abstract available


  20. AULBERT W, Kobbe R, Breuer C, Briem-Richter A, et al
    Hypereosinophilic Syndrome After Liver Transplantation - a Case Report and a Review of the Literature.
    Transplantation. 2017 Mar 4. doi: 10.1097/TP.0000000000001721.
    PubMed     Text format     Abstract available


  21. SIMONETTA F, Pradier A, Masouridi-Levrat S, van Delden C, et al
    Torque Teno Virus Load and Acute Rejection after Orthotopic Liver Transplantation.
    Transplantation. 2017 Mar 4. doi: 10.1097/TP.0000000000001723.
    PubMed     Text format    


  22. LAI Q, Feys E, Karam V, Adam R, et al
    Hepatic Epithelioid Hemangioendothelioma and Adult Liver Transplantation: Proposal for a Prognostic Score Based on the Analysis of the ELTR-ELITA Registry.
    Transplantation. 2017;101:555-564.
    PubMed     Text format     Abstract available


  23. TERRAULT N, Berenguer M, Strasser S, Gadano A, et al
    International Liver Transplant Society Consensus Statement on HEPATITIS C MANAGEMENT IN LIVER TRANSPLANT RECIPIENTS.
    Transplantation. 2017 Mar 1. doi: 10.1097/TP.0000000000001704.
    PubMed     Text format    


  24. TERRAULT NA, McCaughan GW, Curry MP, Gane E, et al
    International Liver Transplant Society Consensus Statement on HEPATITIS C MANAGEMENT IN LIVER TRANSPLANT CANDIDATES.
    Transplantation. 2017 Mar 1. doi: 10.1097/TP.0000000000001708.
    PubMed     Text format    


  25. ARONSOHN A
    Timing is Everything: Managing Hepatitis C in Liver Transplant Candidates.
    Transplantation. 2017 Mar 1. doi: 10.1097/TP.0000000000001703.
    PubMed     Text format    


    February 2017
  26. BRUINSMA BG, Avruch JH, Sridharan GV, Weeder PD, et al
    Peritransplant energy changes and their correlation to outcome after human liver transplantation.
    Transplantation. 2017 Feb 23. doi: 10.1097/TP.0000000000001699.
    PubMed     Text format     Abstract available


  27. EBEL NH, Hsu EK, Berry K, Horslen SP, et al
    Disparities in waitlist and posttransplantation outcomes in liver transplant registrants and recipients 18-24 years old: analysis of the UNOS database.
    Transplantation. 2017 Feb 22. doi: 10.1097/TP.0000000000001689.
    PubMed     Text format     Abstract available


  28. VERNA EC, Brown RS Jr
    HCV Antiviral Therapy In Liver Transplant Candidates and Recipients with Renal Insufficiency.
    Transplantation. 2017 Feb 16. doi: 10.1097/TP.0000000000001688.
    PubMed     Text format     Abstract available


  29. XIE Y, Wu Y, Xin K, Wang JJ, et al
    Delayed Donor Bone Marrow Infusion Induces Liver Transplant Tolerance.
    Transplantation. 2017 Feb 10. doi: 10.1097/TP.0000000000001684.
    PubMed     Text format     Abstract available


  30. BADENOCH A, Sharma A, Gower S, Selzner M, et al
    The Effectiveness and Safety of Tranexamic Acid in Orthotopic Liver Transplantation Clinical Practice: A Propensity Score Matched Cohort Study.
    Transplantation. 2017 Feb 10. doi: 10.1097/TP.0000000000001682.
    PubMed     Text format     Abstract available


  31. WADSTROM J, Ericzon BG, Halloran PF, Bechstein WO, et al
    Advancing Transplantation: New Questions, New Possibilities in Kidney and Liver Transplantation.
    Transplantation. 2017;101 Suppl 2S:S1-S41.
    PubMed     Text format    


  32. CHAPMAN WC, Brown RS Jr, Chavin KD, Sudan D, et al
    Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation.
    Transplantation. 2017;101:341-349.
    PubMed     Text format     Abstract available


  33. LERUT J
    Jan Lerut, MD, PhD: Professor Emeritus of Surgery, Director of the Starzl Abdominal Transplant Unit, University Hospitals Saint Luc and UCL Transplant Centre in Brussels; and Past President, European Society of Organ Transplantation and International
    Transplantation. 2017;101:223-226.
    PubMed     Text format    


    January 2017
  34. GOLDBERG DS, Karp SJ, McCauley ME, Markmann JF, et al
    Interpreting Outcomes in DCDD Liver Transplantation: First Report of the Multi-Center IDOL Consortium.
    Transplantation. 2017 Jan 21. doi: 10.1097/TP.0000000000001656.
    PubMed     Text format     Abstract available


  35. SATAPATHY SK, Vanatta JM, Helmick R, Flowers A, et al
    Outcome of Liver Transplant Recipients With Revascularized Coronary Artery Disease: A Comparative Analysis With and Without Cardiovascular Risk Factors.
    Transplantation. 2017 Jan 17. doi: 10.1097/TP.0000000000001647.
    PubMed     Text format     Abstract available


  36. KIM KH, Kang SH, Jung DH, Yoon YI, et al
    Initial outcomes of pure laparoscopic living donor right hepatectomy in an experienced adult living donor liver transplant center.
    Transplantation. 2017 Jan 9. doi: 10.1097/TP.0000000000001637.
    PubMed     Text format     Abstract available


  37. VINAIXA C, Strasser SI, Berenguer M
    DISEASE REVERSIBILITY IN PATIENTS WITH POSTHEPATITIS C CIRRHOSIS: IS THE POINT OF NO RETURN THE SAME BEFORE AND AFTER LIVER TRANSPLANTATION? A REVIEW.
    Transplantation. 2017 Jan 6. doi: 10.1097/TP.0000000000001633.
    PubMed     Text format     Abstract available



  38. Adherence to and Acceptance of Once-Daily Tacrolimus After Kidney and Liver Transplant: Results From OSIRIS, a French Observational Study: Erratum.
    Transplantation. 2017;101:e40-e41.
    PubMed     Text format    



  39. Impact of Cytomegalovirus Infection on Severe Hepatitis C Recurrence in Patients Undergoing Liver Transplantation: Erratum.
    Transplantation. 2017;101:e40.
    PubMed     Text format    


  40. LIU D, Chan AC, Fong DY, Lo CM, et al
    Evidence-Based Surveillance Imaging Schedule After Liver Transplantation for Hepatocellular Carcinoma Recurrence.
    Transplantation. 2017;101:107-111.
    PubMed     Text format     Abstract available


  41. DEMARTINO ES, Cartin-Ceba R, Findlay JY, Heimbach JK, et al
    Frequency and Outcomes of Patients With Increased Mean Pulmonary Artery Pressure at the Time of Liver Transplantation.
    Transplantation. 2017;101:101-106.
    PubMed     Text format     Abstract available


  42. ONO Y, Perez-Gutierrez A, Yovchev MI, Matsubara K, et al
    Regeneration and Cell Recruitment in an Improved Heterotopic Auxiliary Partial Liver Transplantation Model in the Rat.
    Transplantation. 2017;101:92-100.
    PubMed     Text format     Abstract available


  43. RICH N, Tanriover B, Singal AG, Marrero JA, et al
    Outcomes of Simultaneous Liver Kidney Transplantation in Patients With Hepatocellular Carcinoma.
    Transplantation. 2017;101:e12-e19.
    PubMed     Text format     Abstract available


  44. ASHOKKUMAR C, Soltys K, Mazariegos G, Bond G, et al
    Predicting Cellular Rejection With a Cell-Based Assay: Preclinical Evaluation in Children.
    Transplantation. 2017;101:131-140.
    PubMed     Text format     Abstract available


    December 2016
  45. FREIRE MP, Oshiro IC, Pierrotti LC, Bonazzi PR, et al
    Carbapenem-Resistant Enterobacteriaceae Acquired before Liver Transplantation: Impact on Recipient Outcomes.
    Transplantation. 2016 Dec 22. doi: 10.1097/TP.0000000000001620.
    PubMed     Text format     Abstract available


  46. DIAZ GC, Zerillo J, Singhal A, Hibi T, et al
    Report of the 22nd Annual Congress of the International Liver Transplantation Society.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  47. KIM PT, Fernandez H, Gupta A, Saracino G, et al
    Low measured hepatic artery flow increases rate of biliary strictures in deceased donor liver transplantation: An age dependent phenomenon.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  48. LAU L, Kankanige Y, Rubinstein B, Jones R, et al
    Machine-Learning Algorithms Predict Graft Failure Following Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  49. HAMAGUCHI Y, Kaido T, Okumura S, Kobayashi A, et al
    Impact of skeletal muscle mass index, intramuscular adipose tissue content, and visceral to subcutaneous adipose tissue area ratio on early mortality of living donor liver transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  50. LAI Q, Feys E, Karam V, Adam R, et al
    HEPATIC EPITHELIOID HEMANGIO-ENDOTHELIOMA AND ADULT LIVER TRANSPLANTATION: PROPOSAL FOR A PROGNOSTIC SCORE BASED ON THE ANALYSIS OF THE ELTR-ELITA REGISTRY.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  51. SALAZAR J, Saxena V, Kahn JG, Roberts JP, et al
    Cost-Effectiveness of Direct-Acting Anti-viral Treatment in Hepatitis C-infected Liver Transplant Candidates with Compensated Cirrhosis and Hepatocellular Carcinoma.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  52. CROOME KP, Lee DD, Keaveny AP, Taner CB, et al
    Improving National Results in Liver Transplantation Using Grafts From Donation After Cardiac Death Donors.
    Transplantation. 2016;100:2640-2647.
    PubMed     Text format     Abstract available


  53. CARRILLO CF, Crespo G, de la Revilla J, Castells L, et al
    Successful continuation of HCV treatment following liver transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  54. MILLER CM, Quintini C, Dhawan A, Durand F, et al
    The International Liver Transplant Society (ILTS) Living Donor Liver Transplant Recipient Guideline.
    Transplantation. 2016.
    PubMed     Text format    


    November 2016
  55. BARBIER L, Cesaretti M, Dondero F, Cauchy F, et al
    Liver Transplantation With Older Donors: A Comparison With Younger Donors in a Context of Organ Shortage.
    Transplantation. 2016;100:2410-2415.
    PubMed     Text format     Abstract available


  56. ZAHR ELDEEN F, Roll GR, Derosas C, Rao R, et al
    Preoperative Thromboelastography as a Sensitive Tool Predicting Those at Risk of Developing Early Hepatic Artery Thrombosis After Adult Liver Transplantation.
    Transplantation. 2016;100:2382-2390.
    PubMed     Text format     Abstract available


  57. KRAWCZYK M, Grat M, Adam R, Polak WG, et al
    Liver Transplantation for Hepatic Trauma: A Study From the European Liver Transplant Registry.
    Transplantation. 2016;100:2372-2381.
    PubMed     Text format     Abstract available


  58. MURALI AR, Romero-Marrero C, Miller C, Aucejo F, et al
    Predictors of Successful Downstaging of Hepatocellular Carcinoma Outside Milan Criteria.
    Transplantation. 2016;100:2391-2397.
    PubMed     Text format     Abstract available


    October 2016
  59. ROTELLAR F, Pardo F, Benito A, Zozaya G, et al
    Totally laparoscopic right hepatectomy for living donor liver transplantation. Analysis of a preliminary experience on 5 consecutive cases.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  60. NICASTRO E, Giovannozzi S, Stroppa P, Callegaro AP, et al
    Effectiveness of preemptive therapy for Cytomegalovirus disease in pediatric liver transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  61. IKEGAMI T, Shimagaki T, Kawasaki J, Yoshizumi T, et al
    Eversion technique to prevent biliary stricture after living donor liver transplantation in the universal minimal hilar dissection era.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  62. ALVAREZ-SOTOMAYOR D, Satorres C, Rodriguez-Medina B, Herrero I, et al
    Controlling Diabetes After Liver Transplantation: Room for Improvement.
    Transplantation. 2016;100:e66-e73.
    PubMed     Text format     Abstract available


  63. DEBETTE-GRATIEN M, Woillard JB, Picard N, Sebagh M, et al
    Influence of Donor and Recipient CYP3A4, CYP3A5, and ABCB1 Genotypes on Clinical Outcomes and Nephrotoxicity in Liver Transplant Recipients.
    Transplantation. 2016;100:2129-2137.
    PubMed     Text format     Abstract available


  64. CASSUTO E, Pageaux GP, Cantarovich D, Rostaing L, et al
    Adherence to and Acceptance of Once-Daily Tacrolimus After Kidney and Liver Transplant: Results From OSIRIS, a French Observational Study.
    Transplantation. 2016;100:2099-2106.
    PubMed     Text format     Abstract available


    September 2016
  65. CROOME KP, Lee DD, Keaveny AP, Burcin Taner C, et al
    IMPROVING NATIONAL RESULTS IN LIVER TRANSPLANTATION USING GRAFTS FROM DONATION AFTER CARDIAC DEATH DONORS.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  66. ELFEKI M, Abou Mrad R, Modaresi Esfeh J, Zein N, et al
    Sofosbuvir/Ledipasvir without Ribavirin Achieved High Sustained Virologic Response for Hepatitis C Recurrence after Liver Transplantation: Two-Center Experience.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


    August 2016
  67. SCHLANSKY B, Naugler WE, Orloff SL, Enestvedt CK, et al
    Higher Mortality and Survival Benefit in Obese Patients Awaiting Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  68. POMPOSELLI JJ
    Hepatic Artery Thrombosis (HAT) After Liver Transplant: Not A Surgical Problem?
    Transplantation. 2016.
    PubMed     Text format    


  69. MOHKAM K, Fanget F, Darnis B, Harbaoui B, et al
    Use of systemic vasodilators for the management of Doppler ultrasound arterial abnormalities after orthotopic liver transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  70. MANDELL MS, Smith AR, Dew MA, Gordon DB, et al
    Early Postoperative Pain and its Predictors in the Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL).
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  71. DE CARLIS L, De Carlis R, Lauterio A, Di Sandro S, et al
    Sequential use of normothermic regional perfusion and hypothermic machine perfusion in donation after cardiac death liver transplantation with extended warm ischemia time.
    Transplantation. 2016.
    PubMed     Text format    


  72. DE SIMONE P, Fagiuoli S, Cescon M, De Carlis L, et al
    Use of Everolimus in Liver Transplantation: Recommendations From a Working Group.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  73. FURUICHI M, Fujiwara T, Fukuda A, Kasahara M, et al
    Fulminant hepatic failure as a risk factor for cytomegalovirus infection in children receiving preemptive therapy after living donor liver transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  74. CICALESE L, Shirafkan A, Jennings K, Zorzi D, et al
    Increased risk of death for patients on the waitlist for liver transplant residing at greater distance from specialized liver transplant centers in the USA.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  75. HART A, Schladt DP, Zeglin J, Pyke J, et al
    Predicting outcomes on the liver transplant waiting list in the United States: Accounting for large regional variation in organ availability and priority allocation points.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  76. HAMAGUCHI Y, Kaido T, Okumura S, Kobayashi A, et al
    Proposal of Muscle-MELD score, including muscularity, for prediction of mortality after living donor liver transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  77. MURALI AR, Chandra S, Stewart Z, Blazar BR, et al
    Graft versus Host Disease After Liver Transplantation in Adults: A Case series, Review of Literature, and an Approach to Management.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  78. SALIBA F, Rostaing L, Gugenheim J, Durand F, et al
    Corticosteroid-Sparing and Optimization of Mycophenolic Acid Exposure in Liver Transplant Recipients Receiving Mycophenolate Mofetil and Tacrolimus: A Randomized, Multicenter Study.
    Transplantation. 2016;100:1705-13.
    PubMed     Text format     Abstract available


    July 2016
  79. VIEHMAN JA, Clancy CJ, Clarke L, Shields R, et al
    Surgical site infections after liver transplantation: Emergence of multi-drug resistant bacteria and implications for prophylaxis and treatment strategies.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  80. PICHLER RH, Huskey J, Kowalewska J, Moiz A, et al
    Kidney Biopsies May Help Predict Renal Function following Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  81. GYOTEN K, Mizuno S, Kato H, Murata Y, et al
    A novel predictor of posttransplant portal hypertension in adult-to-adult living donor liver transplantation: increased estimated spleen/graft volume ratio.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  82. GOODRICH NP, Schaubel DE, Smith AR, Merion RM, et al
    National Assessment of Hospitalization Rates for Incident End Stage Renal Disease after Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  83. HAARER J, Riquelme P, Hoffmann P, Schnitzbauer A, et al
    Early Enrichment and Restitution of the Peripheral Blood Treg Pool Is Associated With Rejection-Free Stable Immunosuppression After Liver Transplantation.
    Transplantation. 2016;100:e39-40.
    PubMed     Text format    


  84. POMPOSELLI JJ, Goodrich NP, Emond JC, Humar A, et al
    Patterns of Early Allograft Dysfunction in Adult Live Donor Liver Transplantation: The A2ALL Experience.
    Transplantation. 2016;100:1490-9.
    PubMed     Text format     Abstract available


  85. KROWKA MJ, Fallon MB, Kawut SM, Fuhrmann V, et al
    International Liver Transplant Society Practice Guidelines: Diagnosis and Management of Hepatopulmonary Syndrome and Portopulmonary Hypertension.
    Transplantation. 2016;100:1440-52.
    PubMed     Text format     Abstract available


  86. SULLIVAN T, Weinberg A, Rana M, Patel G, et al
    The Epidemiology and Clinical Features of Clostridium difficile Infection in Liver Transplant Recipients.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


    June 2016
  87. FEIER FH, Seda-Neto J, da Fonseca EA, Candido HL, et al
    Analysis of Factors Associated With Biliary Complications in Children After Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  88. GEISSLER EK, Schnitzbauer AA, Schlitt HJ
    A Rebuttal Letter in Response to: Mammalian Target of Rapamycin Inhibitors Against Hepatocellular Carcinoma Recurrence After Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format    


  89. HAN S, Yang JD, Sinn DH, Ko JS, et al
    Higher Bilirubin Levels of Healthy Living Liver Donors Are Associated With Lower Posttransplant Hepatocellular Carcinoma Recurrence.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  90. HSU CC, Chen CL, Wang CC, Lin CC, et al
    Combination of FDG-PET and UCSF Criteria for Predicting HCC Recurrence After Living Donor Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  91. CHOLONGITAS E
    Mammalian Target of Rapamycin Inhibitors Against Hepatocellular Carcinoma Recurrence After Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format    


  92. NARASIMHAN G, Safwan M, Kota V, Reddy MS, et al
    Donor Outcomes in Living Donor Liver Transplantation-Analysis of 275 Donors From a Single Centre in India.
    Transplantation. 2016;100:1251-6.
    PubMed     Text format     Abstract available


  93. EMOND JC
    Live Donor Liver Transplantation: An International Perspective.
    Transplantation. 2016;100:1182-3.
    PubMed     Text format    



  94. Russell W. Strong, FRCS (Eng), FRACS, FRACDS: Pioneering Live Donor Liver Transplantation.
    Transplantation. 2016;100:1177-9.
    PubMed     Text format    


  95. WERNER JM, Schlitt HJ
    Living Donor Liver Transplantation.
    Transplantation. 2016;100:1173-4.
    PubMed     Text format    


  96. SALVALAGGIO PR, Seda Neto J, Alves JA, Fonseca EA, et al
    Consensus, Dilemmas, and Challenges in Living Donor Liver Transplantation in Latin America.
    Transplantation. 2016;100:1161-4.
    PubMed     Text format     Abstract available


  97. WANG CW, Feng S, Covinsky KE, Hayssen H, et al
    A Comparison of Muscle Function, Mass, and Quality in Liver Transplant Candidates: Results From the Functional Assessment in Liver Transplantation Study.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


    May 2016
  98. DEW MA, DiMartini AF, Ladner DP, Simpson MA, et al
    Psychosocial Outcomes 3 to 10 Years After Donation in the Adult to Adult Living Donor Liver Transplantation Cohort Study.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  99. TOMODA T, Kato H, Mizukawa S, Yabe S, et al
    Biliary Anastomotic Stricture After Adult Living Donor Liver Transplantation With Duct-to-Duct Reconstruction: Outcome After Endoscopic Treatment Including Rendezvous Procedure.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


    April 2016
  100. KUBAL C, Mangus R, Fridell J, Saxena R, et al
    Optimization of Perioperative Conditions to Prevent Ischemic Cholangiopathy in Donation After Circulatory Death Donor Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  101. GHINOLFI D, De Simone P, Tincani G, Pezzati D, et al
    Beyond the Limit: Approaching Systematic Use of Nonagenarian Donors in Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format    


  102. BRITO-COSTA A, Pereira-da-Silva L, Papoila AL, Alves M, et al
    Factors Associated With Changes in Body Composition Shortly After Orthotopic Liver Transplantation: The Potential Influence of Immunosuppressive Agents.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  103. BRAUN HJ, Dodge JL, Roll GR, Freise CE, et al
    Impact of Graft Selection on Donor and Recipient Outcomes After Living Donor Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  104. MILLER CM, Durand F, Heimbach JK, Kim-Schluger L, et al
    The International Liver Transplant Society Guidelines on Living Liver Donation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  105. DE CARLIS L, Lauterio A, De Carlis R, Ferla F, et al
    Donation After Cardiac Death Liver Transplantation After More Than 20 Minutes of Circulatory Arrest and Normothermic Regional Perfusion.
    Transplantation. 2016;100:e21-2.
    PubMed     Text format    


  106. VITALONE MJ, Wei L, Fujiki M, Lau AH, et al
    Liver microRNA Profile of Induced Allograft Tolerance.
    Transplantation. 2016;100:781-90.
    PubMed     Text format     Abstract available


  107. MAS VR, Portilla D, Maluf DG
    Biomarkers of Transplant Tolerance: A Provisional Analysis for an Unmet Need.
    Transplantation. 2016;100:705-6.
    PubMed     Text format    


  108. REDDY MS, Shrivastav M, Kaliamoorthy I, Kota V, et al
    Safety of Live Liver Donation by Individuals With G6PD Deficiency: Initial Results and Comparative Study.
    Transplantation. 2016;100:814-8.
    PubMed     Text format     Abstract available


  109. LI AH, Lam NN, Naylor KL, Garg AX, et al
    Early Hospital Readmissions After Transplantation: Burden, Causes, and Consequences.
    Transplantation. 2016;100:713-8.
    PubMed     Text format     Abstract available


    March 2016
  110. DE SIMONE P, Romagnoli R, Tandoi F, Carrai P, et al
    Early Introduction of Subcutaneous Hepatitis B Immunoglobulin Following Liver Transplantation for Hepatitis B Virus Infection: A Prospective, Multicenter Study.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  111. CAO Y, Shahrestani S, Chew HC, Crawford M, et al
    Donation After Circulatory Death for Liver Transplantation: A Meta-Analysis on the Location of Life Support Withdrawal Affecting Outcomes.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  112. VANDEKERCKHOVE K, Coomans I, De Bruyne E, De Groote K, et al
    Evaluation of Exercise Performance, Cardiac Function, and Quality of Life in Children After Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  113. SEDA-NETO J, Antunes da Fonseca E, Pugliese R, Candido HL, et al
    Twenty Years of Experience in Pediatric Living Donor Liver Transplantation: Focus on Hepatic Artery Reconstruction, Complications and Outcomes.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  114. ADDOLORATO G, Bataller R, Burra P, DiMartini A, et al
    Liver Transplantation for Alcoholic Liver Disease.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  115. KHORSANDI SE, Yip VS, Cortes M, Jassem W, et al
    Does Donation After Cardiac Death Utilization Adversely Effect Hepatocellular Cancer Survival?
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  116. FAISAL N, Bilodeau M, Aljudaibi B, Hirsch G, et al
    Sofosbuvir-Based Antiviral Therapy Is Highly Effective In Recurrent Hepatitis C in Liver Transplant Recipients: Canadian Multicenter "Real-Life" Experience.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  117. MANAS D, Burnapp L, Andrews PA
    Summary of the British Transplantation Society UK Guidelines for Living Donor Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  118. FOSTER BJ, Dahhou M, Zhang X, Dharnidharka VR, et al
    High Risk of Liver Allograft Failure During Late Adolescence and Young Adulthood.
    Transplantation. 2016;100:577-84.
    PubMed     Text format     Abstract available


    February 2016
  119. RELA M, Reddy MS
    "Failure to Rescue" as a Novel Quality Metric in Pediatric Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format    


  120. CRAMM SL, Waits SA, Englesbe MJ, Bucuvalas JC, et al
    Failure to Rescue as a Quality Improvement Approach in Transplantation: A First Effort to Evaluate This Tool in Pediatric Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  121. LING Q, Xu X, Wang B, Li L, et al
    The Origin of New-Onset Diabetes After Liver Transplantation: Liver, Islets, or Gut?
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  122. WESTERKAMP AC, Karimian N, Matton AP, Mahboub P, et al
    Oxygenated Hypothermic Machine Perfusion After Static Cold Storage Improves Hepatobiliary Function of Extended Criteria Donor Livers.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  123. TOUSSAINT A, Weiss E, Khoy-Ear L, Janny S, et al
    Prognostic Value of Preoperative Brain Natriuretic Peptide Serum Levels in Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  124. WERNER JM, Vermehren J
    New HCV Therapies and Liver Transplantation.
    Transplantation. 2016;100:260-1.
    PubMed     Text format    


  125. SUHR OB, Larsson M, Ericzon BG, Wilczek HE, et al
    Survival After Transplantation in Patients With Mutations Other Than Val30Met: Extracts From the FAP World Transplant Registry.
    Transplantation. 2016;100:373-81.
    PubMed     Text format     Abstract available


    January 2016
  126. LIMAYE AP, La Rosa C, Longmate J, Diamond DJ, et al
    Plasma IL-10 Levels to Guide Antiviral Prophylaxis Prevention of Late-Onset Cytomegalovirus Disease, in High Risk Solid Kidney and Liver Transplant Recipients.
    Transplantation. 2016;100:210-6.
    PubMed     Text format     Abstract available


  127. POMFRET EA
    Killing Two Birds With One Stone: Antineoplastic Immunosuppression.
    Transplantation. 2016;100:14-5.
    PubMed     Text format    


  128. LEUVENINK HG
    Warming Up--Not Only Essential for Athletes?
    Transplantation. 2016;100:10-1.
    PubMed     Text format    


  129. HOYER DP, Mathe Z, Gallinat A, Canbay AC, et al
    Controlled Oxygenated Rewarming of Cold Stored Livers Prior to Transplantation: First Clinical Application of a New Concept.
    Transplantation. 2016;100:147-52.
    PubMed     Text format     Abstract available


  130. VIJGEN S, Wyss C, Meylan P, Bisig B, et al
    Fatal Outcome of Multiple Clinical Presentations of Human Herpesvirus 8-related Disease After Solid Organ Transplantation.
    Transplantation. 2016;100:134-40.
    PubMed     Text format     Abstract available


    December 2015
  131. DU H, Sheng M, Wu L, Zhang Y, et al
    Hydrogen-Rich Saline Attenuates Acute Kidney Injury After Liver Transplantation via Activating p53-Mediated Autophagy.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  132. TANIMINE N, Tanaka Y, Abe T, Piao J, et al
    Functional Behavior of NKp46-Positive Intrahepatic Natural Killer Cells Against Hepatitis C Virus Reinfection After Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  133. ABERG F, Nordin A, Toivonen L, Isoniemi H, et al
    Early Predictors of Long-term Outcomes of HCV-Negative Liver Transplant Recipients Having Survived the First Postoperative Year.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  134. DOYCHEVA I, Leise MD, Watt KD
    The Intestinal Microbiome and the Liver Transplant Recipient: What We Know and What We Need to Know.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  135. GLOVER TE, Watson CJ, Gibbs P, Bradley JA, et al
    Conversion From Calcineurin to Mammalian Target of Rapamycin Inhibitors in Liver Transplantation: A Meta-Analysis of Randomized Controlled Trials.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  136. THORSEN T, Aandahl EM, Bennet W, Olausson M, et al
    Transplantation With Livers From Deceased Donors Older Than 75 Years.
    Transplantation. 2015;99:2534-42.
    PubMed     Text format     Abstract available


    November 2015
  137. MAS V, Archer KJ, Maluf D
    The High-Risk Age Window After Pediatric Liver Transplantation: Modeling Allograft Loss Using Mathematical Tools.
    Transplantation. 2015.
    PubMed     Text format    


  138. OLMEDILLA L, Lisbona CJ, Perez-Pena JM, Lopez-Baena JA, et al
    Early Measurement of Indocyanine Green Clearance Accurately Predicts Short-Term Outcomes After Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  139. GEISSLER EK, Schnitzbauer AA, Zulke C, Lamby PE, et al
    Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  140. ISMAIL SY, Duerinckx N, van der Knoop MM, Timmerman L, et al
    Toward a Conceptualization of the Content of Psychosocial Screening in Living Organ Donors: An Ethical Legal Psychological Aspects of Transplantation Consensus.
    Transplantation. 2015;99:2413-21.
    PubMed     Text format     Abstract available


  141. IGARASHI Y, Onoe T, Ohdan H
    The Role of Liver Sinusoidal Endothelial Cells in Induction of Carbohydrate Reactive B Cells Tolerance Through the Programmed Death 1/Programmed Death Ligand 1 Pathway.
    Transplantation. 2015;99:2325-36.
    PubMed     Text format     Abstract available


  142. MARIANTE-NETO G, Brandao AB
    Model for End-Stage Liver Disease: Is Sex-Based Creatinine Correction a Viable Strategy for Black Females?
    Transplantation. 2015;99:2337-40.
    PubMed     Text format     Abstract available


  143. NOBEL YR, Goldberg DS
    Variable Use of Model for End-Stage Liver Disease Exception Points in Patients With Neuroendocrine Tumors Metastatic to the Liver and Its Impact on Patient Outcomes.
    Transplantation. 2015;99:2341-6.
    PubMed     Text format     Abstract available


    October 2015
  144. ROSSI AP, Vella JP
    Acute Kidney Disease After Liver and Heart Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  145. SINGAL AK, Hasanin M, Kaif M, Wiesner R, et al
    Nonalcoholic Steatohepatitis is the Most Rapidly Growing Indication for Simultaneous Liver Kidney Transplantation in the United States.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  146. EDMUNDS C, Ekong UD
    Autoimmune Liver Disease Post Liver Transplantation-A Summary and Proposed Areas for Future Research.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


    September 2015
  147. CASTON JJ, Castells L, Varo E, Gomez MA, et al
    Impact of Cytomegalovirus Infection on Severe Hepatitis C Recurrence in Patients Undergoing Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  148. CHOI Y, Yi NJ, Ko JS, Moon JS, et al
    Reappraisal of the Role of Portacaval Shunting in the Growth of Patients With Glycogen Storage Disease Type I in the Era of Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  149. LEE J, Yoo YJ, Lee JM, Park YJ, et al
    Sevoflurane Versus Desflurane on the Incidence of Postreperfusion Syndrome During Living Donor Liver Transplantation: A Randomized Controlled Trial.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  150. UEDA Y, Uemoto S
    Interferon-Free Therapy for Hepatitis C in Liver Transplant Recipients.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  151. PAPE E, Scala-Bertola J, Petitpain N, Jouzeau JY, et al
    Management of Tacrolimus-Telaprevir Drug-Drug Interaction in a Liver Transplant Patient With Hepatitis C Virus: Practical Considerations.
    Transplantation. 2015;99:e163-e164.
    PubMed     Text format    


  152. GIACOMONI A, Concone G, Di Sandro S, Lauterio A, et al
    Hepatocellular Carcinoma Progression While on Waiting List for Liver Transplantation.
    Transplantation. 2015;99:e155-e156.
    PubMed     Text format    


  153. MANGUS RS, Fridell JA, Kubal CA, Loeffler AL, et al
    Worse Long-term Patient Survival and Higher Cancer Rates in Liver Transplant Recipients With a History of Smoking.
    Transplantation. 2015;99:1862-1868.
    PubMed     Text format     Abstract available


  154. MANGUS RS, Lutz AJ, Fridell JA, Kubal CA, et al
    Minimal Improvement in Glomerular Filtration Rate in the First Year After Liver Transplantation.
    Transplantation. 2015;99:1855-1861.
    PubMed     Text format     Abstract available


  155. ERICZON BG, Wilczek HE, Larsson M, Wijayatunga P, et al
    Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative?
    Transplantation. 2015;99:1847-1854.
    PubMed     Text format     Abstract available


  156. MEHROTRA S, Kilambi V, Gilroy R, Ladner DP, et al
    The Authors' Reply.
    Transplantation. 2015;99:e160-1.
    PubMed     Text format    


  157. GENTRY SE, Segev DL, Kasiske BL, Mulligan DC, et al
    Robust Models Support Redistricting Liver Allocation to Reduce Geographic Disparity.
    Transplantation. 2015;99:e159-60.
    PubMed     Text format    


  158. PARAJULI S, Foley D, Djamali A, Mandelbrot D, et al
    Renal Function and Transplantation in Liver Disease.
    Transplantation. 2015;99:1756-64.
    PubMed     Text format     Abstract available


  159. IACOB S, Cicinnati VR, Lindemann M, Heinemann FM, et al
    Donor-Specific Anti-HLA Antibodies and Endothelial C4d Deposition-Association With Chronic Liver Allograft Failure.
    Transplantation. 2015;99:1869-75.
    PubMed     Text format     Abstract available


    August 2015
  160. GEHRAU RC, Mas VR, Dumur CI, Suh JL, et al
    Donor Hepatic Steatosis Induce Exacerbated Ischemia-Reperfusion Injury Through Activation of Innate Immune Response Molecular Pathways.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  161. MCELROY LM, Schmidt KA, Richards CT, Lapin B, et al
    Early Postoperative Emergency Department Care of Abdominal Transplant Recipients.
    Transplantation. 2015;99:1652-7.
    PubMed     Text format     Abstract available


  162. BECKER BN, Becker YT
    Evaluating the Emergency Department as a Site of Transplant Care.
    Transplantation. 2015;99:1549-50.
    PubMed     Text format    


  163. RAVAIOLI M, Neri F, Lazzarotto T, Bertuzzo VR, et al
    Immunosuppression Modifications Based on an Immune Response Assay: Results of a Randomized, Controlled Trial.
    Transplantation. 2015;99:1625-32.
    PubMed     Text format     Abstract available


    July 2015
  164. LOCKE JE, Durand C, Reed RD, MacLennan PA, et al
    Long-Term Outcomes After Liver Transplantation Among Human Immunodeficiency Virus-Infected Recipients.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  165. PATERNO F, Wima K, Hoehn RS, Cuffy MC, et al
    Use of Elderly Allografts in Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  166. FISCHER L, Saliba F, Kaiser GM, De Carlis L, et al
    Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study.
    Transplantation. 2015;99:1455-62.
    PubMed     Text format     Abstract available


  167. SEMER NB
    Awaiting Liver Transplantation.
    Transplantation. 2015;99:e48.
    PubMed     Text format    


  168. CHAPMAN JR, Pomfret EA
    President's Address: International Liver Transplantation Society.
    Transplantation. 2015;99:1301.
    PubMed     Text format    


    June 2015
  169. SINGH N, Winston DJ, Limaye AP, Pelletier S, et al
    Performance Characteristics of Galactomannan and beta-d-Glucan in High-Risk Liver Transplant Recipients.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  170. GHABRIL M, Agarwal S, Lacerda M, Chalasani N, et al
    Portal Vein Thrombosis Is a Risk Factor for Poor Early Outcomes After Liver Transplantation: Analysis of Risk Factors and Outcomes for Portal Vein Thrombosis in Waitlisted Patients.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  171. SHAPIRO AM
    Donor-Specific Antibody in Pediatric Liver Transplantation-Identifying a Tree by its Fruit.
    Transplantation. 2015.
    PubMed     Text format    


  172. ROCHE B, Roque-Afonso AM, Nevens F, Samuel D, et al
    Rational Basis for Optimizing Short and Long-Term Hepatitis B Virus Prophylaxis Post Liver Transplantation. Role of Hepatitis B Immune Globulin.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  173. WOZNIAK LJ, Hickey MJ, Venick RS, Vargas JH, et al
    Donor-Specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  174. ALHAMAD T, Uemura T, Lehman E, Spatz C, et al
    Utilization of donors after cardiac death organs for simultaneous liver and kidney transplantation.
    Transplantation. 2015;99:e40-1.
    PubMed     Text format    


  175. WADEI HM, Taner CB
    Simultaneous liver-kidney transplantation from donation after cardiac death donors: is there a better way to use these organs?
    Transplantation. 2015;99:e39.
    PubMed     Text format    


  176. ASCHER NL
    Nancy L. Ascher, MD, PhD: Professor and Chair, Department of Surgery, UCSF; Past-President, ASTS; President-elect, The Transplantation Society.
    Transplantation. 2015;99:1106.
    PubMed     Text format    


  177. GOLDIN MM, Khubutia MSh, Evseev AK, Goldin MM, et al
    Noninvasive diagnosis of dysfunctions in patients after organ transplantation by monitoring the redox potential of blood serum.
    Transplantation. 2015;99:1288-92.
    PubMed     Text format     Abstract available


  178. WU G, Cruz RJ
    Liver inclusion improves outcomes of intestinal retransplantation in adults.
    Transplantation. 2015;99:1265-72.
    PubMed     Text format     Abstract available


    May 2015
  179. HAYASHI K, Uchida H, Takaoka C, Izawa Y, et al
    Discrepancy in Psychological Attitudes Toward Living Donor Liver Transplantation Between Recipients and Donors.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  180. SCHNITZBAUER AA, Sothmann J, Baier L, Bein T, et al
    Calcineurin Inhibitor Free De Novo Immunosuppression in Liver Transplant Recipients With Pretransplant Renal Impairment: Results of a Pilot Study (PATRON07).
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  181. CHENG Q, He SQ, Gao D, Lei B, et al
    Early Application of Auxiliary Partial Orthotopic Liver Transplantation in Murine Model of Wilson Disease.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  182. GOLSE N, Bucur PO, Faitot F, Bekheit M, et al
    Spontaneous Splenorenal Shunt in Liver Transplantation: Results of Left Renal Vein Ligation Versus Renoportal Anastomosis.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  183. LONGENECKER JC, Estrella MM, Segev DL, Atta MG, et al
    Patterns of Kidney Function Before and After Orthotopic Liver Transplant: Associations With Length of Hospital Stay, Progression to End-Stage Renal Disease, and Mortality.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  184. MOROSO V, van Cranenbroek B, Mancham S, Sideras K, et al
    Prominent HLA-G Expression in Liver Disease But Not After Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


    April 2015
  185. SALEM R, Vouche M, Baker T, Herrero JI, et al
    Pretransplant Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt in Patients With Complete Obliterative Portal Vein Thrombosis.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


    March 2015
  186. SINGH N, Sifri CD, Silveira FP, Miller R, et al
    Cryptococcosis in Patients With Cirrhosis of the Liver and Posttransplant Outcomes.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  187. RANA A, Kaplan B, Riaz IB, Porubsky M, et al
    Geographic inequities in liver allograft supply and demand: does it affect patient outcomes?
    Transplantation. 2015;99:515-20.
    PubMed     Text format     Abstract available


  188. CEULEMANS LJ, De Hertogh G, Van Cromphaut S, Vermeire S, et al
    Nonsteroidal anti-inflammatory drug-induced intestinal graft loss 12 years after transplantation.
    Transplantation. 2015;99:e18-9.
    PubMed     Text format    


  189. VERGHESE PS, Schmeling DO, Knight JA, Matas AJ, et al
    The impact of donor viral replication at transplant on recipient infections posttransplant: a prospective study.
    Transplantation. 2015;99:602-8.
    PubMed     Text format     Abstract available


    February 2015
  190. KOIKE K, Takaki A, Yagi T, Iwasaki Y, et al
    Enhancement of Programmed Death Ligand 2 on Hepatitis C Virus Infected Hepatocytes by Calcineurin Inhibitors.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  191. MEHROTRA S, Kilambi V, Gilroy R, Ladner DP, et al
    Modeling the allocation system: principles for robust design before restructuring.
    Transplantation. 2015;99:278-81.
    PubMed     Text format     Abstract available


    August 2014
  192. CHANG Y, Gallon L, Shetty K, Chang Y, et al
    Simulation Modeling of the Impact of Proposed New Simultaneous Liver and Kidney Transplantation Policies.
    Transplantation. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: